Clinical Trial Update: HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients [NA]

View source ↗

Summary

This completed clinical trial investigates whether adding pegylated interferon alfa-2a can promote HBsAg loss in patients with chronic hepatitis B who are HBeAg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: José Antonio Carrion | Conditions: Chronic Hepatitis B (HBeAg-negative) | NA | Status: COMPLETED